Literature DB >> 9700118

Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.

G F Zhu1, B Sun, S F Niu, Y Y Cai, K Lin, R Lindwall, B Robertson.   

Abstract

Intratracheal administration of surfactant and inhaled nitric oxide (INO) have had variable effects in clinical trials on patients with acute respiratory distress syndrome (ARDS). We hypothesized that combined treatment with exogenous surfactant and INO may have effects in experimental ARDS. After intravenous infusion of oleic acid in adult rabbits and 4-6 h of ventilation, there was more than a 40% reduction in both dynamic compliance (Cdyn) of the respiratory system and functional residual capacity (FRC), a 50% increment of respiratory resistance (Rrs), a 70% reduction in PaO2 /FIO2, and an increase in intrapulmonary shunting (Q S/Q T) from 4.4 to 33.5%. The animals were then allocated to groups receiving (1) neither surfactant nor INO (control), (2) 100 mg/kg of surfactant (S) administered intratracheally, (3) 20 ppm INO (NO), or (4) 100 mg/kg of surfactant and 20 ppm INO (SNO), and subsequently ventilated for 6 h. After the period of ventilation, the animal lungs were used for analysis of disaturated phosphatidylcholine (DSPC) and total proteins (TP) in bronchoalveolar lavage fluid (BALF), and for determination of alveolar volume density (VV). The animals in the control group had the lowest survival rate, and no improvement in lung mechanics and blood oxygenation, whereas those in the S group had a modest but statistically significant improvement in Cdyn, Rrs, PaO2 and FRC, reduced Q S/Q T, lowered minimum surface tension (gammamin) of BALF, and increased DSPC/ TP and alveolar VV. The NO group had increased PaO2 and reduced Q S/Q T. The SNO group showed improved Cdyn, Rrs, FRC, DSPC/TP, alveolar VV, and gammamin of BALF comparable to the S group, but there was a further increase in survival rate and PaO2, and additional reduction in Q S/Q T and TP in BALF. These results indicate that, in this animal model of ARDS, a combination of surfactant therapy and INO is more effective than either treatment alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700118     DOI: 10.1164/ajrccm.158.2.9711107

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Tracheal acid or surfactant instillation raises alveolar surface tension.

Authors:  Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2018-05-17

2.  Our paper 20 years later: Inhaled nitric oxide for the acute respiratory distress syndrome--discovery, current understanding, and focussed targets of future applications.

Authors:  R Rossaint; K Lewandowski; W M Zapol
Journal:  Intensive Care Med       Date:  2014-09-09       Impact factor: 17.440

Review 3.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

4.  Tetrahydrocoptisine protects rats from LPS-induced acute lung injury.

Authors:  Weifeng Li; Huimin Huang; Xiaofeng Niu; Ting Fan; Hua Hu; Yongmei Li; Huan Yao; Huani Li; Qingli Mu
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

5.  A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome.

Authors:  Robert Lindwall; Mats Blennow; Mats Svensson; Baldvin Jonsson; Eva Berggren-Boström; Martino Flanby; Per-Arne Lönnqvist; Claes Frostell; Mikael Norman
Journal:  Intensive Care Med       Date:  2005-03-22       Impact factor: 17.440

Review 6.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

7.  The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats.

Authors:  Xiwen Gao; Yi Huang; Yipin Han; Chun-Xue Bai; Guifang Wang
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

8.  WISP1 mediates lung injury following hepatic ischemia reperfusion dependent on TLR4 in mice.

Authors:  Yao Tong; Zhuang Yu; Renlingzi Zhang; Xibing Ding; Zhixia Chen; Quan Li
Journal:  BMC Pulm Med       Date:  2018-12-06       Impact factor: 3.317

9.  The effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletion.

Authors:  Johann M van Zyl; Johan Smith; Arthur Hawtrey
Journal:  Drug Des Devel Ther       Date:  2013-03-11       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.